The canton of Basel-Stadt has displayed the most striking performance in the Swiss Venture Capital Report. Last year, more than…

Researchers from Basel are working on the development of a therapy in which pre-prepared immune cells can be used to…

Opterion is moving from the canton of Obwalden to Muttenz in the canton of Basel-Landschaft in order to benefit from…

The biotech company Evolva is introducing L-arabinose to the market. This product is a natural sugar blocker and can be…

Zifo RnD Solutions, a global provider of IT solutions for research-based organizations, opens its latest subsidiary in Basel. With Zifo…

German pharma group Boehringer Ingelheim is to acquire the Basel life sciences company NBE-Therapeutics for €1.18 billion. NBE-Therapeutics specializes in…

The Basel-based pharmaceutical company Noema Pharma has raised a total of 54 million Swiss francs as part of a Series…